CYP27B1 and COVID-19: It has been demonstrated that enzyme 25(OH)D 1-α hydroxylase (CYP27B1) is upregulated in activated immune cells, so circulating 25(OH)D levels could be lowered by the COVID-19-associated systemic inflammatory response (29).